Project 1: Enabling Technologies for Medically-Important Cannabis-Based Products
Location: 22nd Century Laboratories, Buffalo Niagara Medical Campus, Buffalo, New York
Objective: To identify tools for the manipulation of cannabinoid biosynthesis. We have identified a number of crucial areas in the emerging medical area of cannabis biotechnology and are aiming to develop tools which will be needed by a mature cannabis biotech industry.
Opportunity: 22nd Century/Botanical Genetics, by virtue of using its own laboratories, will own outright all intellectual property. Enabling technologies will be key to the development and production of commercial quantities of marijuana cannabinoids – including CBD and CBC – that show great promise in treating neurological disorders and other diseases.